Biomerica, Inc. Stock

$3.15

1.56% yesterday

Nasdaq, Jun 27, 10:00 pm CET

ISIN

US09061H3075

Symbol

BMRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Biomerica, Inc. Stock price

$3.15

-56.77 94.74% 5Y

Nasdaq, Closing price Fri, Jun 27 2025

-0.05 1.56%

ISIN

US09061H3075

Symbol

BMRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

$8.0m

Enterprise Value

$5.0m

Net debt

$-3.1m

Cash

$3.1m

Shares outstanding

2.6m

Valuation (TTM | estimate)

P/E

negative | -

P/S

1.41 | -

EV/Sales

0.87 | -

EV/FCF

negative

P/B

1.45

Financial Health

Equity Ratio

71.22%

Return on Equity

-90.70%

ROCE

-88.99%

ROIC

-140.58%

Debt/Equity

0.00

Financials (TTM | estimate)

Revenue

$5.7m | -

EBITDA

$-4.5m | -

EBIT

$-5.1m

Net Income

$-4.9m | -

Free Cash Flow

$-4.3m

Growth (TTM | estimate)

Revenue

5.19% | -

EBITDA

32.07% | -

EBIT

23.64%

Net Income

23.62% | -

Free Cash Flow

20.41%

Margin (TTM | estimate)

Gross

13.47%

EBITDA

-79.04% | -

EBIT

-89.80%

Net

-85.42% | -

Free Cash Flow

-75.47%

EPS

$-2.02

FCF per Share

$-1.68

Short interest

2.22%

Employees

64.00

Rev per Employee

$80.00k

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

??

7 Analysts have issued a Biomerica, Inc. forecast:

6x Buy

86%

More details on Analyst Estimates Including Price Targets

7 Analysts have issued a Biomerica, Inc. forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from Biomerica, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Feb '25		+/- %
Revenue	5.68 5.68	5% 5% 100%
- Direct Costs	4.91 4.91	3% 3% 86%
Gross Profit	0.77 0.77	24% 24% 14%
- Selling and Administrative Expenses	4.83 4.83	15% 15% 85%
- Research and Development Expense	1.04 1.04	35% 35% 18%
EBITDA	-4.49 -4.49	32% 32% -79%
- Depreciation and Amortization	0.61 0.61	771% 771% 11%
EBIT (Operating Income) EBIT	-5.10 -5.10	24% 24% -90%
Net Profit	-4.85 -4.85	24% 24% -85%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Biomerica, Inc. Stock News

Neutral

GlobeNewsWire

●

2 days ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Scott Madel as Chief Commercial Officer.

Neutral

GlobeNewsWire

●

22 days ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Mr. Chin brings over 20 years of financial experience across public and private healthcare organizations Mr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financing Mr.

Neutral

GlobeNewsWire

●

23 days ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced diagnostic-guided therapies, today announced that data from its pivotal clinical trial evaluating the inFoods® IBS test in treating IBS sufferers has been published in the June 2025 issue of Gastroenterology , the official journal of the American Gastroenterological Association and the ...

More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office	United States
CEO	Zackary Irani
Employees	64
Founded	1971
Website	biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now